SBA Paper No.13


This quiz is for logged in users only.



Leave a comment

9 thoughts on “SBA Paper No.13

  • Christopher Smith

    I was having a look into question 4 –

    The KDIGO AKI guideline state the below order of preference for vascular access for RRT in AKI:

    When choosing a vein for insertion of a dialysis
    catheter in patients with AKI, consider these
    preferences (Not Graded):
    – First choice: right jugular vein;
    – Second choice: femoral vein;
    – Third choice: left jugular vein;
    – Last choice: subclavian vein with preference for
    the dominant side.

    Regarding coagulopathy, AAGBI Safe Vascular Access seems to preference femoral if risk of bleeding (however as stated not considered higher as INR not >1.8.

    And states regarding minimum length of adult CVC catheters:

    Fixed-length catheters:
    -15 cm for right internal jugular vein (IJV),
    – 20 cm for left internal jugular or right axillary/subclavian vein, and
    – 24 cm for left axillary/subclavian or femoral vein,
    are the usual minimum selection length for adults.

    So the answer would seem be Femoral 25cm line? (that’s what I’d do anyway!)

  • Nick Wilson

    Great questions…call me a coward but I disagree with Q5 – whilst i can see the merit in a rotigotine patch this is a specialist intervention. Neurologists would be delighted 24h day to speak to one of us on how to administer the patch and whether that is the right management given what dopamine needs that patient has. For example, would you go for a 1mg/24 patch, or perhaps go for 4mg? Or maybe go a little wild and put two on – one on each arm? The BJA seems to suggest calling an expert….

    • Nick Wilson

      But, i can see – the semantics and the joy of these questions….as is calling a neurologist a treatment? maybe for insomnia?
      So – rotigotine – could be the best ‘treatment’. Guess my point is to be careful reading the question – in the exam dont just put rotigotine! If perhaps it says what is the next best management?